The Department of Medical Education has relieved Dr. H.C. Lokesh from the post of District Surgeon of Sri Chamarajendra ...

Finding the right treatment for erectile dysfunction (ED) can feel overwhelming with so many options out there! Rugiet, ...

On Wednesday, Hims & Hers Health Inc (HIMS) stock saw a decline, ending the day at $30.34 which represents a decrease of $-0.34 or -1.11% from the prior close of $30.68. The stock opened at $31.49 and ...

Hims & Hers achieved a 44% YoY increase in Q3 2024, surpassing 2 million active users. Find out what positions HIMS as a key ...

The bitter irony is that Republican policies in states with high obesity rates only exacerbate the gaps in health outcomes.

Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions ...

Hims & Hers (HIMS) is up 14.0%, or $4.29 to $34.97.Don't Miss our Black Friday Offers:Unlock your investing potential with TipRanks Premium ...

(Goldman, 11/27) Bloomberg: Hims & Hers Shares Rally As FDA Pick Marty Makary Seen As Major Ally Hims & Hers Health Inc. shares surged 24% to close at fresh record after Hunterbrook Media said the ...

Nutrafol is a leader in supplement-based hair loss treatments, offering a natural way to support healthy hair growth. Their ...

Shares of Hims & Hers were on fire Monday because the FDA's new leader seems to be a fan of the company's business model.

3. Shares of virtual care company Hims & Hers spiked after the news that a telehealth ally could be running the FDA, Bloomberg reported Nov. 25. 4. Sesame provides compounded versions of the popular ...

Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) has received a consensus rating of “Hold” from the sixteen analysts ...